Head of Marketing– D-PLEX100

Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company that focuses on innovative products that meet the needs of underserved patients. As an industry leader in providing unique, accessible, and high-quality medications, Azurity leverages its integrated capabilities and vast partner network to continually expand its broad commercial product portfolio and robust late-stage pipeline. The company’s patient-centric products span the cardiovascular, neurology, endocrinology, gastro-intestinal, institutional, and orphan markets, and have benefited millions of patients.

For more information,  .

Azurity Pharmaceuticals is proud to be an inclusive workplace and an Equal Opportunity Employer. Azurity's success is attributable to our incredibly talented, dedicated team that focuses on benefiting the lives of patients by bringing the best science and commitment to quality into everything that we do. We seek highly motivated individuals with the dedication, integrity, and creative spirit needed to thrive in our organization.

About the Role

Azurity Pharmaceuticals is a privately held specialty pharmaceutical company focused on innovative products that meet the needs of underserved patients. Within the Surgical Business Unit— our hospital-focused, targeted-delivery specialty business — we are preparing to launch D-PLEX
100, a locally administered, extended-release surgical anti-infective for the prevention of surgical site infection.

We are seeking a Head of Marketing to own US brand strategy and launch for D-PLEX
100. Reporting to the VP, NA Commercial Brand Executive for Oncology, this individual is the US marketing lead for the asset — responsible for brand strategy, positioning, launch planning and readiness, and in-line execution across the hospital and surgical setting. D-PLEX
100 is an inpatient, DRG-reimbursed product whose adoption is governed at the account level by institutional Pharmacy & Therapeutics (P&T) committees; success depends on winning formulary approval and building protocol-level demand, not on individual prescribing alone. The role leads a small brand team, directs external agencies, and partners closely with Market Access/HEOR, Medical Affairs, Sales, Regulatory, and Program Management to bring a differentiated, reimbursement-dependent hospital product to market.

This role has two direct reports — a Director, Brand Marketing (primarily, but not limited to, in-line HCP marketing execution and campaign/agency management) and a Senior Manager, Brand Marketing – Institutional (primarily, but not limited to, institutional and account-facing materials, congress and KOL logistics)

The ideal candidate brings a minimum of 12 years in pharmaceutical or biotech, including at least 6 years of US marketing experience working with DRG-reimbursed hospital, surgical, and/or anti-infective products, and prior people-management experience. This is a US-focused role in a fast-paced, launch-stage environment that rewards a hands-on, collaborative leader.

Key Responsibilities

Brand Strategy & Execution

• Own US brand strategy for D-PLEX
  100 — positioning, value proposition, messaging, and the integrated marketing plan — aligned to corporate and commercial objectives and to the DRG/NTAP reimbursement pathway.
• Develop and execute the launch and in-line marketing plan for the hospital and surgical setting, ensuring timely development, medical/legal/regulatory review, production, and deployment of campaigns and materials.
• Monitor brand performance, KPIs, and market dynamics — including P&T and formulary access, protocol adoption, and account-level uptake — to optimize strategy and inform tactical pivots.
• Commission and interpret primary and secondary market research to build surgeon, pharmacy, and institutional insight and to inform brand strategy.

Institutional Access & P&T Strategy

• Build the account-level adoption strategy for a P&T-governed product: the formulary value story, P&T submission tools, and pull-through plan that move D-PLEX
  100 from approval to protocol inclusion at target institutions.
• Partner with Market Access/HEOR and Contracting to align the brand on pricing, coding, DRG economics,…